Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis

被引：96

作者：

Caocci, G. ^{[1
,2
]}

Murgia, F. ^{[1
]}

Podda, L. ^{[3
]}

Solinas, A. ^{[4
]}

Atzeni, S. ^{[1
]}

La Nasa, G. ^{[1
,2
]}

机构：

[1] Univ Cagliari, Dept Med Sci, Hematol Unit, Cagliari, Italy

[2] R Binaghi Hosp, Bone Marrow Transplant Ctr, Cagliari, Italy

[3] Univ Hosp, Hematol Unit, Sassari, Italy

[4] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy

来源：

LEUKEMIA | 2014年 / 28卷 / 01期

关键词：

D O I：

10.1038/leu.2013.235

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：225 / 227

页数：4

共 10 条

[1]

Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: A case report [J].

Claudia Colomba ;

Raffaella Rubino ;

Lucia Siracusa ;

Francesco Lalicata ;

Marcello Trizzino ;

Lucina Titone ;

Manlio Tolomeo .

BMC Research Notes, 5 (1)

[2]

Ruxolitinib for myelofibrosis therapy: current context, pros and cons [J].

Pardanani, A. .

LEUKEMIA, 2012, 26 (07) :1449-1451

[3]

Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA [J].

Puro, Robyn ;

Schneider, Robert J. .

JOURNAL OF VIROLOGY, 2007, 81 (14) :7351-7362

[4]

Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment [J].

Shi, Hong ;

Lu, Lu ;

Zhang, Ning-Ping ;

Zhang, Shun-Cai ;

Shen, Xi-Zhong .

WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (27) :3617-3622

[5]

Mutations and prognosis in primary myelofibrosis [J].

Vannucchi, A. M. ;

Lasho, T. L. ;

Guglielmelli, P. ;

Biamonte, F. ;

Pardanani, A. ;

Pereira, A. ;

Finke, C. ;

Score, J. ;

Gangat, N. ;

Mannarelli, C. ;

Ketterling, R. P. ;

Rotunno, G. ;

Knudson, R. A. ;

Susini, M. C. ;

Laborde, R. R. ;

Spolverini, A. ;

Pancrazzi, A. ;

Pieri, L. ;

Manfredini, R. ;

Tagliafico, E. ;

Zini, R. ;

Jones, A. ;

Zoi, K. ;

Reiter, A. ;

Duncombe, A. ;

Pietra, D. ;

Rumi, E. ;

Cervantes, F. ;

Barosi, G. ;

Cazzola, M. ;

Cross, N. C. P. ;

Tefferi, A. .

LEUKEMIA, 2013, 27 (09) :1861-1869

[6]

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis [J].

Verstovsek, Srdan ;

Mesa, Ruben A. ;

Gotlib, Jason ;

Levy, Richard S. ;

Gupta, Vikas ;

DiPersio, John F. ;

Catalano, John V. ;

Deininger, Michael ;

Miller, Carole ;

Silver, Richard T. ;

Talpaz, Moshe ;

Winton, Elliott F. ;

Harvey, Jimmie H., Jr. ;

Arcasoy, Murat O. ;

Hexner, Elizabeth ;

Lyons, Roger M. ;

Paquette, Ronald ;

Raza, Azra ;

Vaddi, Kris ;

Erickson-Viitanen, Susan ;

Koumenis, Iphigenia L. ;

Sun, William ;

Sandor, Victor ;

Kantarjian, Hagop M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :799-807

[7]

Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy [J].

Wang, Yin-Hua ;

Fan, Lei ;

Wang, Li ;

Zhang, Run ;

Xu, Ji ;

Fang, Cheng ;

Li, Jian-Yong ;

Xu, Wei .

SUPPORTIVE CARE IN CANCER, 2013, 21 (05) :1265-1271

[8]

Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy [J].

Watanabe, Tsunamasa ;

Tanaka, Yasuhito .

HEPATOLOGY RESEARCH, 2013, 43 (02) :113-121

[9]

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy [J].

Yeo, W ;

Johnson, PJ .

HEPATOLOGY, 2006, 43 (02) :209-220

[10]

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection [J].

Zerbini, Alessandro ;

Pilli, Massimo ;

Boni, Carolina ;

Fisicaro, Paola ;

Penna, Amalia ;

Di Vincenzo, Paola ;

Giuberti, Tiziana ;

Orlandini, Alessandra ;

Raffa, Giuseppina ;

Pollicino, Teresa ;

Raimondo, Giovanni ;

Ferrari, Carlo ;

Missale, Gabriele .

GASTROENTEROLOGY, 2008, 134 (05) :1470-1481

← 1 →